# Viewpoint Molecular Targeting, Inc.: Form D filings

Viewpoint Molecular Targeting, Inc., a biotechnology company in Coralville, IA, filed 5 Form D notices with the SEC between 2019 and 2021. The latest, on January 15, 2021, reports $14.3 million sold of a $15.8 million offering to 29 investors.

Find out what Viewpoint Molecular Targeting, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20Viewpoint%20Molecular%20Targeting%2C%20Inc.%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=Viewpoint%20Molecular%20Targeting%2C%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fviewpoint-molecular-targeting-inc-1768245)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20Viewpoint%20Molecular%20Targeting%2C%20Inc.%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=Viewpoint%20Molecular%20Targeting%2C%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fviewpoint-molecular-targeting-inc-1768245)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in Iowa](https://specstream.ai/data/form-d/state/iowa): 206 rows, by operating companies, filed since November 1, 2024, $10.30, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/iowa
- [Form D filings in Biotechnology](https://specstream.ai/data/form-d/industry/biotechnology): 1,568 rows, by operating companies, filed since November 1, 2024, $78.40, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/biotechnology

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 2500 CROSSPARK ROAD E-116, Coralville, IA, 52241
- Phone: (865) 356-1861
- Industry: Biotechnology
- Entity type: Corporation
- Incorporated in: Delaware
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506(b)
- SEC identifier (CIK): 1768245

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Jan 15, 2021 | Amendment | $15,847,498 | $14,258,742 | $1,588,756 | 29 | Nov 20, 2020 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1768245/000176824521000001/0001768245-21-000001-index.htm) |
| Dec 30, 2020 | Amendment | $15,847,498 | $12,038,744 | $3,808,754 | 28 | Nov 20, 2020 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1768245/000176824520000003/0001768245-20-000003-index.htm) |
| Dec 4, 2020 | New notice | $15,847,498 | $8,843,739 | $7,003,759 | 26 | Nov 20, 2020 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1768245/000176824520000002/0001768245-20-000002-index.htm) |
| Jun 18, 2020 | Amendment | $2,000,000 | $750,000 | $1,250,000 | 10 | Feb 6, 2019 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1768245/000176824520000001/0001768245-20-000001-index.htm) |
| Feb 19, 2019 | New notice | $2,000,000 | $600,000 | $1,400,000 | 7 | Feb 6, 2019 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1768245/000176824519000002/0001768245-19-000002-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Michael Schultz | Executive Officer, Director |  |
| Curtis Nelson | Director |  |
| Heyward Coleman | Executive Officer, Director |  |
| Cameron Gray | Director |  |
| Frances Johnson | Executive Officer, Director |  |

[Every Form D from the week of Jan 11, 2021](https://specstream.ai/data/form-d/week/2021-01-11) · [All recent filings in Iowa](https://specstream.ai/data/form-d/state/iowa) · [All recent Biotechnology filings](https://specstream.ai/data/form-d/industry/biotechnology)

Read from SEC EDGAR. Amount sold is what Viewpoint Molecular Targeting, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).